0 Commentaires
0 Parts
278 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Commentaires 0 Parts 144 Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Precision Oncology Drugs Market Share and Cancer Therapy Innovations" Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the...0 Commentaires 0 Parts 170 Vue 0 Aperçu
-
Precision Oncology Revolution: Antibody Drug Conjugates (ADCs) Market Trends 2026The landscape of cancer treatment is undergoing a seismic shift. Gone are the days when "scorched earth" chemotherapy was the only viable path for late-stage patients. Today, we are living in the era of the "magic bullet" , a concept first envisioned by Paul Ehrlich over a century ago now realized through the Antibody Drug Conjugates (ADCs) Market. By combining the laser-like precision of...0 Commentaires 0 Parts 497 Vue 0 Aperçu
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Oncology Drugs Market to Reach USD 503.13 Billion by 2033, Growing at 11.6% CAGRMarket Overview The global oncology drugs market size was valued at USD 193.04 billion in 2024 and is projected to grow from USD 209.57 billion in 2025 to USD 503.13 billion by 2033, exhibiting a CAGR of 11.6% during the forecast period (2025-2033). The global Oncology Drugs market is witnessing swift transformation driven by new consumer behaviors, increased...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek